Emerging opportunistic yeast infections in haematology patients.
Hofmeyr
Ann
A
Department of Infectious Diseases, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, Victoria, Australia.
Slavin
Monica A
MA
D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy / Q000382:microbiology*; D009181:Mycoses / Q000188:drug therapy / Q000382:microbiology*; D009894:Opportunistic Infections / Q000188:drug therapy / Q000382:microbiology*; D012441:Saccharomyces cerevisiae / Q000302:isolation & purification*
D000935:Antifungal Agents; D000666:Amphotericin B